16May

Life Science Group transfers operations to new facility in Sandy, Bedfordshire

Life Science Group (LSG) is a privately owned biologicals manufacturing company producing contract manufacturing solutions for a variety of Life Science applications.


LSG has recently completed a move to new, larger facilities in Sandy, Bedfordshire. The facilities will offer expanded manufacturing capabilities available in new cleanroom suites equipped to GMP standards.


“We are delighted to be moving to our new facility. The additional manufacturing space this offers, together with enlarged laboratory facilities, will enable the company to continue to grow and provide tailored solutions to our customers,” said LSG Managing Director, Jenny Murray.


“This new facility will increase our manufacturing capacity and offers bespoke manufacturing in Grade C and D cleanrooms, together with our standard ISO Class 3/5 cleanroom suites. The increased frozen and chilled storage facilities will also benefit our customers requiring us to provide logistics services,” added Ms. Murray.


The new facility will also offer training workshops to students who require vocational cleanroom training to enhance their course content. The company is working closely with a number of universities in the locality to tailor these services.


Life Science Group is formed of three divisions providing quality custom biological products and exceptional customer services to Pharma, Biotech, CRO and Universities worldwide.


Antibody Production Service (APS) provides contract generation of de novo monoclonal and polyclonal antibodies with supporting services.


Life Science Production (LSP) provides contract manufacture of cell culture sera, media, buffers and reagents. LSP also offers a large range of off-the-shelf cell culture sera, including foetal bovine serum and Human AB serum, media, buffers and other reagents.
Diagnostic Kit Services (DKS) offers aseptic product fill and kit design and packaging services.


For more information
www.lifesciencegroup.co.uk


ENDS

Related

Press Release - RQM+ Appoints Life Science Executive Margaret Keegan as New CEO

RQM+, the world’s leading provider of regulatory, clinical and quality solutions to the MedTech ind...

Read More >

Maintain Sample Integrity with New RNA Complete BCT™

New RNA Complete BCT™ is a direct draw blood collection tube, now available in the UK from Alpha La...

Read More >

Isohelix Double Registers its DNA Saliva and Buccal Cell Collectors with the Chinese CFDA.

Isohelix announces that their range of GenefiX DNA Saliva and Isohelix DNA Buccal Cell Collectors ar...

Read More >

QIAGEN announces FDA approval of PartoSure

Germantown, Maryland, and Hilden, Germany, April 20, 2018 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prim...

Read More >

Multiplicom launches complete CE-IVD marked solution in Europe for all BRCA testing needs

Belgium, 16 May 2017 – Multiplicom, an Agilent Technologies Company, announced today the extended C...

Read More >

BioIVT Acquires Commercial Blood Bank Tennessee Blood Services

Transaction expands BioIVT’s donor network and increases its capacity to provide fresh whole blood,...

Read More >